Drugs / SAR161271
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01053728 | Feb → May 2010 | type 1 diabetes mellitus | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAR161271 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01053728 ↗ |
| Route | Subcutaneous | “Route of administration: subcutaneous” NCT01053728 ↗ |